More tools:Markets·Screener·Research Chat

Revolution Medicines, Inc. Common Stock (RVMD) Financial Statements

Revolution Medicines, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00829F4Q7
XNAS · usd
184.97▲ 1.02 (0.55%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)$0.00
Net Income (TTM)-$1.4B
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close183.95
Day's Range183.92 – 188.69
52-Week Range34.00 – 193.83
Volume3.08M
Avg Volume3.10M
Share Statistics
Shares Outstanding200.2M
Employees883
ExchangeXNAS
Listed2020-02-13

Key questions about Revolution Medicines, Inc. Common Stock (RVMD)

What is Revolution Medicines, Inc. Common Stock's Market Cap?
Revolution Medicines, Inc. Common Stock's Market Cap is $37.0B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Enterprise Value?
Revolution Medicines, Inc. Common Stock's Enterprise Value is $36.8B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's EV / EBITDA?
Revolution Medicines, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Revenue (TTM)?
Revolution Medicines, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Net Income (TTM)?
Revolution Medicines, Inc. Common Stock's Net Income (TTM) is -$1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's EBITDA?
Revolution Medicines, Inc. Common Stock's EBITDA is -$1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Diluted EPS (TTM)?
Revolution Medicines, Inc. Common Stock's Diluted EPS (TTM) is -6.85, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Net Debt?
Revolution Medicines, Inc. Common Stock's Net Debt is $0.00, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Non-operating income (expense), net:
Interest income
Interest expense—
Change in fair value of warrant liability
Other expense, net———
Total non-operating income (expense), net
Loss before income taxes
Net loss
Net loss per share attributable to common stockholders, basic and diluted————
Weighted-average common shares used to compute net loss per share, basic and diluted————
Comprehensive loss:
Net loss
Other comprehensive gain (loss):
Unrealized gain (loss) on investments, net
Comprehensive loss